Edwards Undeterred By Latest Speed Bump In Transcatheter Mitral Valve Program
This article was originally published in The Gray Sheet
Executive Summary
Edwards has temporarily paused the FORTIS clinical program evaluating a new transcatheter mitral valve to resolve valve thrombosis issues that emerged in the first 20 patients.